Crescent Biopharma Inc. logo

Crescent Biopharma Inc.

CBIO | NASDAQ
Chart Builder DCF Calculator
$12.89
-$0.59 (-4.38%)
Nov 2, 2026, 1:16 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
-153.94M -37.88M -36.9M -46.69M -63.43M -51.03M
Depreciation & Amortization
84K 35.17K 153.3K 207.15K 264.6K 270.75K
Stock-Based Compensation
13.3M 4.77M 3.56M 3.86M 6.09M 6.9M
Other Working Capital
2.55M 1.7M -2.46M -3.52M -1.18M 3.28M
Other Non-Cash Items
82.4M 814.48K 864.87K 828.51K 751.21K 680.85K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-13.37M 1.16M -2.56M -4.66M -1.17M 3.93M
Operating Cash Flow
-71.53M -31.1M -34.88M -46.46M -57.49M -39.24M
Capital Expenditures
-72.92M -9.97K -21.39K -84.19K -14.94K -68.51K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-72M 30K n/a n/a n/a n/a
Investing Cash Flow
-72.92M 20.03K -21.39K -84.19K -14.94K -68.51K
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-177K n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.27M 5.4K 116.5K n/a 25.03K 319.3K
Financial Cash Flow
322.98M 5.4K 28.82M 4.16M 10.72M 18.14M
Net Cash Flow
178.53M -31.07M -6.08M -42.38M -46.78M -21.17M
Free Cash Flow
-144.45M -31.11M -34.9M -46.54M -57.5M -39.31M
Adj. Free Cash Flow
-157.75M -35.88M -38.46M -50.4M -63.59M -46.21M
Maintenance CapEx
-66.8M -9.97K -21.39K -84.19K -14.94K n/a
Growth CapEx
-6.12M n/a n/a n/a n/a -68.51K
Owner Earnings
-138.33M -31.11M -34.9M -46.54M -57.5M -39.24M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.